124 related articles for article (PubMed ID: 7373088)
1. Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection.
Smith CB; Charette RP; Fox JP; Cooney MK; Hall CE
J Infect Dis; 1980 May; 141(5):548-54. PubMed ID: 7373088
[TBL] [Abstract][Full Text] [Related]
2. Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.
Gilbert BE; Wilson SZ; Knight V; Couch RB; Quarles JM; Dure L; Hayes N; Willis G
Antimicrob Agents Chemother; 1985 Mar; 27(3):309-13. PubMed ID: 3888102
[TBL] [Abstract][Full Text] [Related]
3. Treatment of influenza A (H1N1) virus infection with ribavirin aerosol.
Wilson SZ; Gilbert BE; Quarles JM; Knight V; McClung HW; Moore RV; Couch RB
Antimicrob Agents Chemother; 1984 Aug; 26(2):200-3. PubMed ID: 6486761
[TBL] [Abstract][Full Text] [Related]
4. Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers.
Magnussen CR; Douglas RG; Betts RF; Roth FK; Meagher MP
Antimicrob Agents Chemother; 1977 Oct; 12(4):498-502. PubMed ID: 921245
[TBL] [Abstract][Full Text] [Related]
5. Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A.
Cohen A; Togo Y; Khakoo R; Waldman R; Sigel M
J Infect Dis; 1976 Jun; 133 Suppl():A114-120. PubMed ID: 778307
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin small-particle-aerosol treatment of influenza B virus infection.
Bernstein DI; Reuman PD; Sherwood JR; Young EC; Schiff GM
Antimicrob Agents Chemother; 1988 May; 32(5):761-4. PubMed ID: 3293527
[TBL] [Abstract][Full Text] [Related]
7. Oral ribavirin treatment of influenza A and B.
Stein DS; Creticos CM; Jackson GG; Bernstein JM; Hayden FG; Schiff GM; Bernstein DI
Antimicrob Agents Chemother; 1987 Aug; 31(8):1285-7. PubMed ID: 3307623
[TBL] [Abstract][Full Text] [Related]
8. Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus.
Togo Y; McCracken EA
J Infect Dis; 1976 Jun; 133 Suppl():A109-13. PubMed ID: 778306
[TBL] [Abstract][Full Text] [Related]
9. Ribavirin aerosol treatment of influenza.
Knight V; Gilbert BE
Infect Dis Clin North Am; 1987 Jun; 1(2):441-57. PubMed ID: 3332797
[TBL] [Abstract][Full Text] [Related]
10. The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis.
Ray CG; Icenogle TB; Minnich LL; Copeland JG; Grogan TM
J Infect Dis; 1989 May; 159(5):829-36. PubMed ID: 2775346
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) in a double-blind study during an outbreak of influenza.
Salido-Rengell F; Nasser-Quinones H; Briseno-Garcia B
Ann N Y Acad Sci; 1977 Mar; 284():272-7. PubMed ID: 360901
[TBL] [Abstract][Full Text] [Related]
12. Ribavirin aerosol treatment of influenza B virus infection.
McClung HW; Knight V; Gilbert BE; Wilson SZ; Quarles JM; Divine GW
JAMA; 1983 May; 249(19):2671-4. PubMed ID: 6341642
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin aerosol treatment of influenza B virus infection.
McClung HW; Knight V; Gilbert BE; Wilson SZ; Quarles JM; Couch RB; Divine GW; Gordon WH; Thurston JM; Atmar RL
Trans Assoc Am Physicians; 1983; 96():284-93. PubMed ID: 6093312
[TBL] [Abstract][Full Text] [Related]
14. Serum antibody responses in naturally occurring influenza A virus infection determined by enzyme-linked immunosorbent assay, hemagglutination inhibition, and complement fixation.
Madore HP; Reichman RC; Dolin R
J Clin Microbiol; 1983 Dec; 18(6):1345-50. PubMed ID: 6655040
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial.
Rodriguez WJ; Hall CB; Welliver R; Simoes EA; Ryan ME; Stutman H; Johnson G; Van Dyke R; Groothuis JR; Arrobio J
J Pediatr; 1994 Jul; 125(1):129-35. PubMed ID: 8021762
[TBL] [Abstract][Full Text] [Related]
16. Ribavirin small-particle aerosol treatment of influenza.
Knight V; McClung HW; Wilson SZ; Waters BK; Quarles JM; Cameron RW; Greggs SE; Zerwas JM; Couch RB
Lancet; 1981 Oct; 2(8253):945-9. PubMed ID: 6117726
[TBL] [Abstract][Full Text] [Related]
17. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
Smee DF; Wong MH; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
[TBL] [Abstract][Full Text] [Related]
18. [New therapeutic strategies in influenza infections in patients at risk. Controlled study of ribavirin].
Pellegrino M; Baldini EV; Amorico MG; Bisetti A
Clin Ter; 1987 Jul; 122(1):25-31. PubMed ID: 2973893
[No Abstract] [Full Text] [Related]
19. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
20. Ribavirin for influenza and respiratory syncytial virus infections.
Lancet; 1983 Sep; 2(8349):554-5. PubMed ID: 6136701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
